Evidence map›Paper›PMID 42519115›Full record

ArticleInternational journal of pharmaceutics: X2026

ZIF-8 nanoplatform coordinating Zn

Xin'an Wang, Mingming Xu, Haoyu Wang, Yifan Ding, Yifan Liu, Weidong Zhou, Jun Xiang, Youyang Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of pharmaceutics: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin'an WangDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Mingming XuDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Haoyu WangDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Yifan DingDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Yifan LiuDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Weidong ZhouDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Jun XiangDepartment of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
Youyang ZhangDepartment of Geriatric Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc homeostasis dysregulation is a significant feature in prostate cancer (PCa), characterized by a marked decrease in intracellular Zn

Indexed as

Antitumor ImmunitycGAS-STING PathwayNanoplatform (PT-c-di-GMP/OVA@ZIF-8)Prostate Cancer TherapyZinc Homeostasis

Identifiers

PMID42519115
PMCPMC13382595

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.